Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study

• Verfasst von: Nikoghosyan, Anna [VerfasserIn]
• Verfasst von: Rauch, Geraldine [VerfasserIn]
• Verfasst von: Münter, Marc [VerfasserIn]
• Verfasst von: Jensen, Alexandra D. [VerfasserIn]
• Verfasst von: Combs, Stephanie [VerfasserIn]
• Verfasst von: Kieser, Meinhard [VerfasserIn]
• Verfasst von: Debus, Jürgen [VerfasserIn]
• Titel: Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
• Verf.angabe: Anna V. Nikoghosyan, Geraldine Rauch, Marc W. Münter, Alexandra D. Jensen, Stephanie E. Combs, Meinhard Kieser, Jürgen Debus
• E-Jahr: 2010
• Jahr: 5 November 2010
• Umfang: 6 S.
• Fussnoten: Gesehen am 22.05.2023
• Titel Quelle: Enthalten in: BMC cancer
• Ort Quelle: London : BioMed Central, 2001
• Jahr Quelle: 2010
• Band/Heft Quelle: 10(2010), Artikel-ID 606, Seite 1-6
• ISSN Quelle: 1471-2407
• DOI: doi:10.1186/1471-2407-10-606
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Chondrosarcomas
• Sach-SW: Chordoma
• Sach-SW: Local Control Rate
• Sach-SW: Proton Therapy
• Sach-SW: Skull Base
• K10plus-PPN: 184588194X

Abstract

Low and intermediate grade chondrosarcomas are relative rare bone tumours. About 5-12% of all chondrosarcomas are localized in base of skull region. Low grade chondrosarcoma has a low incidence of distant metastasis but is potentially lethal disease. Therefore, local therapy is of crucial importance in the treatment of skull base chondrosarcomas. Surgical resection is the primary treatment standard. Unfortunately the late diagnosis and diagnosis at the extensive stage are common due to the slow and asymptomatic growth of the lesions. Consequently, complete resection is hindered due to close proximity to critical and hence dose limiting organs such as optic nerves, chiasm and brainstem. Adjuvant or additional radiation therapy is very important for the improvement of local control rates in the primary treatment. Proton therapy is the gold standard in the treatment of skull base chondrosarcomas. However, high-LET (linear energy transfer) beams such as carbon ions theoretically offer advantages by enhanced biologic effectiveness in slow-growing tumours.